KidsBrainIT: a new multi-centre, multi-disciplinary, multi-national paediatric brain monitoring collaboration - Lo T, Piper I, Depreitere B, Meyfroidt G, Poca M, Sahuquillo J, Durduran T, Enblad P, Nilsson P, Ragauskas A, Kiening K, Morris K, Agbeko R, Levin R, Weitz J, Park C, Davis P.
OBJECTIVES: Validated optimal cerebral perfusion pressure (CPP) treatment thresholds in children do not exist. To improve the intensive care unit (ICU) management of the paediatric traumatic brain injury (TBI) population, we are forming a new paediatric mu... (Source: SafetyLit)
Source: SafetyLit - March 7, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

LimFlow hopes to give end-stage CLI patients an alternative to amputation with its pDVA system
Earlier this year the FDA accepted LimFlow’s Percutaneous Deep Vein Arterialization system into its Breakthrough Device Program. CEO Dan Rose is hopeful that that designation, along with an increased feasibility study size, will help get the company’s pDVA product to critical limb ischemia patients in the US facing limb amputations with no other options. “There are over 270,000 ischemic major amputations in U.S. and Europe every year and these patients have no option today,” Rose said in an interview with MassDevice.com. “We’re really trying to provide a new solution for patients who have exhausted ...
Source: Mass Device - March 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Vascular LimFlow Source Type: news

Dataset of MR stroke images could advance treatment
Researchers have made available a collection of 304 T1-weighted MR images so...Read more on AuntMinnie.comRelated Reading: FDA expands use window for stroke treatment device Study finds gadolinium leaks into eyes of stroke patients Perfusion imaging expands window for stroke treatment Infervision debuts AI stroke screening software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 21, 2018 Category: Radiology Source Type: news

Paragonix Tech wins CE Mark for heart transport devices
Paragonix Technologies said today it won CE Mark approval in the European Union for its SherpaPak and SherpaPerfusion cardiac transport systems. The SherpaPak system consists of a single-use, disposable device designed for the hypothermic static preservation and transportation of the donor hearts, while the SherpaPerfusion system is a single-use, disposable device designed for hypothermic oxygenated perfusion preservation and transport of donor hearts. “Having followed the extensive research and product development activities at Paragonix Technologies over the past few years, I am impressed by the intuitive designs o...
Source: Mass Device - February 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Regulatory/Compliance Surgical Transplants Paragonix Technologies Source Type: news

FDA expands use window for stroke treatment device
The U.S. Food and Drug Administration (FDA) has expanded the treatment window...Read more on AuntMinnie.comRelated Reading: FDA clears Viz.AI's stroke detection software Study finds gadolinium leaks into eyes of stroke patients Perfusion imaging expands window for stroke treatment FDA clears 2 clot retrieval devices for stroke Interventionalists: Proceed with caution for mechanical blood clot removal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 15, 2018 Category: Radiology Source Type: news

SNMMI, ASNC offer guidelines for myocardial perfusion imaging with PET
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American...Read more on AuntMinnie.comRelated Reading: SNMMI to watch for job-related health problems SNMMI names Thomas editor for technology journal SNMMI posts criteria for somatostatin receptor PET Radiologist wins ASNC's 1st clinical abstract award Medical societies expand collaboration on cardiac registry ASNC, SNMMI advise on cardiac sarcoidosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 13, 2018 Category: Radiology Source Type: news

Masimo wins CE Mark for Eve newborn CCHD screening app
Masimo (NSDQ:MASI) said today it won CE Mark approval in the European Union for its Eve critical congenital heart disease newborn screening application which runs on the company’s Rad-97 and Radical-7 pulse co-oximeters. The Eve application is designed to streamline CCHD screenings by providing visual instructions, animations and automatic synchronization algorithms with a detailed display of screening results, the Irvine, Calif.-based company said. Eve also enables the incorporation of perfusion index measurements into screening, which Masimo said has been shown to increase sensitivity to the detection of CCHD in ...
Source: Mass Device - February 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Diagnostics Regulatory/Compliance Masimo Source Type: news

Is CT or MR perfusion better for diagnosing CAD?
Recent advances in scanner technology have made the use of CT stress myocardial...Read more on AuntMinnie.comRelated Reading: Perfusion imaging expands window for stroke treatment ASNC releases guidance on MPI in women CTA plus stress tests help predict heart attacks Reconstruction kernel cuts artifacts in CT MPI ISCT: Is CT perfusion dead beyond the head? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2018 Category: Radiology Source Type: news

Delcath touts 500th commercial Chemosat treatment in Europe
Delcath Systems (NSDQ:DCTH) said today that doctors in Europe performed the 500th percutaneous hepatic perfusion therapy treatment using Delcath’s Chemosat delivery system. The drug-device combo has been available in certain European markets since 2012. Get the full story at our sister site, Drug Delivery Business News. The post Delcath touts 500th commercial Chemosat treatment in Europe appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 2, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Pharmaceuticals Wall Street Beat Delcath Systems Inc. Source Type: news

Neovasc wins German reimbursement for Reducer system
Neovasc (NSDQ:NVCN) said today that it won reimbursement coverage from the German Institute for the Hospital Renumberation System for its Reducer device designed to treat refractory angina. The Reducer system is designed to alter blood flow in the heart’s circulatory system to increase perfusion of oxygenated blood to ischemic areas of heart muscle, and can be placed in a minimally invasive transvenous procedure, Neovasc said. The German body gave the device Nub status 1 designation for 2018, the highest priority designation available, up from a previously set Nub 4 status, the Vancouver-based company said. The des...
Source: Mass Device - February 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Neovasc Inc. Source Type: news

Perfusion imaging expands window for stroke treatment
Perfusion MR and CT images can help clinicians identify stroke patients who...Read more on AuntMinnie.comRelated Reading: Infervision debuts AI stroke screening software UCLA offers ambulatory stroke care with mobile CT 3D-printed model helps prepare for stroke clot removal CTA helps direct use of clot removal for stroke patients MRI technique boosts stroke images (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 25, 2018 Category: Radiology Source Type: news

Cerebral Blood Flow Predicts Later Cognitive Function in Older Individuals Cerebral Blood Flow Predicts Later Cognitive Function in Older Individuals
Cerebral blood flow (CBF) in healthy older people predicts cognitive function four years later, according to results from an arterial-spin-labeling perfusion-MRI study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 16, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Tiered CT Protocol Boosts Efficiency, Speed of CAD Diagnosis Tiered CT Protocol Boosts Efficiency, Speed of CAD Diagnosis
The protocol, which includes dynamic perfusion imaging, helps rule out low-risk patients with stable angina while comprehensively assessing those with CAD who may benefit from revascularization, Dutch researchers suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 9, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Miracor closes $30m Series D
Miracor Medical Systems said today it closed a $30.2 million (EU €25 million) round of funding as part of Series D financing round with funds slated to support further development and commercialization of its PiCSO impulse system, and announced it is moving its headquarters from Austria to Belgium. The company’s PiCSO therapy is designed to be used during stenting procedures for patients affected by acute myocardial infarcts to improve pressure in the coronary venous system to improve microcirculatory flow and improve perfusion in the infarcted area. The round was led by Shenzhen, China-based Ming Capital and co-le...
Source: Mass Device - January 4, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Miracor Source Type: news

Advanced MRI can detect placental perfusion abnormalities in pregnancies complicated by fetal CHD
(Children's National Health System) In pregnancies complicated by fetal congenital heart disease, global placental perfusion was significantly decreased and regional variation of placental perfusion significantly increased as pregnancies progressed, findings that point to non-invasive imaging providing an early warning of placental dysfunction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 4, 2018 Category: International Medicine & Public Health Source Type: news